MORE►
Eli Lilly
The Fort Worth oncology company tapped former Salarius Pharmaceuticals CEO David Arthur to lead its push toward commercialization, including a planned IND for a rare pediatric brain cancer program.
NanOlogy Names CEO as Its Tumor-Targeted Cancer Drugs Near Key Regulatory Milestones
by Sandra Engelland | Dec 30, 2025
The Fort Worth oncology company tapped former Salarius Pharmaceuticals CEO David Arthur to lead its push toward commercialization, including a planned IND for a rare pediatric brain cancer program.
by Lance Murray |
Oct 30, 2025
Prime Data Centers said Donncha Ó Tuama and former Tesla exec Michael Hildebrand will help shape the company's next chapter, driving innovation and project delivery across its expanding data center portfolio.
MORE►
by Lance Murray |
Jun 5, 2025
Co-founded by Chief Scientific Advisor Daniel J. Siegwart of UT Southwestern and CEO RA Session II, Signify Bio said it harnesses the human body for the production of in situ protein therapeutics. The round was led by Actium Group with participation from the Gates Foundation Strategic Investment Fund, Danaher Ventures LLC, Eli Lilly and Company, and BrightEdge, the American Cancer Society's VC arm.
MORE►
